The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing

<b>Background/Objectives</b>: Heart failure (HF) constitutes a complex clinical syndrome that is highly prevalent worldwide, comprises a serious prognosis, and results in a reduced quality of life. Exercise capacity is one of the most significant parameters involved in the prognosis in H...

Full description

Saved in:
Bibliographic Details
Main Authors: Magdalena Dudek, Marta Kałużna-Oleksy, Filip Sawczak, Agata Kukfisz, Aleksandra Soloch, Jacek Migaj, Maciej Lesiak, Ewa Straburzyńska-Migaj
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/1/60
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588974914273280
author Magdalena Dudek
Marta Kałużna-Oleksy
Filip Sawczak
Agata Kukfisz
Aleksandra Soloch
Jacek Migaj
Maciej Lesiak
Ewa Straburzyńska-Migaj
author_facet Magdalena Dudek
Marta Kałużna-Oleksy
Filip Sawczak
Agata Kukfisz
Aleksandra Soloch
Jacek Migaj
Maciej Lesiak
Ewa Straburzyńska-Migaj
author_sort Magdalena Dudek
collection DOAJ
description <b>Background/Objectives</b>: Heart failure (HF) constitutes a complex clinical syndrome that is highly prevalent worldwide, comprises a serious prognosis, and results in a reduced quality of life. Exercise capacity is one of the most significant parameters involved in the prognosis in HF patients. Our objective was to evaluate the relationship between the selected cardiopulmonary exercise testing (CPET) parameters and the concentration of novel biomarker sST2 in a group of patients with heart failure with reduced ejection fraction (HFrEF). <b>Methods</b>: A group of 135 patients with HFrEF was enrolled in this prospective cohort study. Patients were in the stable phase of the disease in the prior 4 weeks and received optimal medical treatment. Clinical and biochemical parameters were investigated. All patients performed maximal CPET. <b>Results</b>: The mean (SD) concentration of sST2 was 45.5 ± 39.2 ng/mL. Based on the CPET results, the cut-off value (52.377 ng/mL) was established, optimal for the discrimination of relative peakVO<sub>2</sub> < 12 mL/kg/min. Patients were divided into two groups according to sST2 cut-off values determined with an ROC curve (AUC 0.692, 95% CI: 0.567–0.816). The mean relative peakVO<sub>2</sub> in patients with higher sST2 was 14.5 ± 4.6 mL/kg/min, while in the second group, it was 17.6 ± 5.2 (<i>p</i> = 0.002). In the sST2 ≥ 52.377 ng/mL group, 55.6% of patients achieved VO<sub>2</sub> < 50%. Subjects with lower sST2 values obtained higher values of PETCO<sub>2</sub> (<i>p</i> < 0.001) and higher values of pulse O<sub>2</sub> (<i>p</i> = 0.01). VE/VCO<sub>2</sub>slope (<i>p</i> = 0.002) was higher in patients with increased sST2 concentration. <b>Conclusions</b>: The concentration of sST2 protein is substantially associated with the clinical severity of heart failure with reduced left ventricular ejection fraction assessed by functional capacity through CPET.
format Article
id doaj-art-6167856dbd5d4941baaabf4488f2ed58
institution Kabale University
issn 2227-9059
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-6167856dbd5d4941baaabf4488f2ed582025-01-24T13:23:52ZengMDPI AGBiomedicines2227-90592024-12-011316010.3390/biomedicines13010060The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise TestingMagdalena Dudek0Marta Kałużna-Oleksy1Filip Sawczak2Agata Kukfisz3Aleksandra Soloch4Jacek Migaj5Maciej Lesiak6Ewa Straburzyńska-Migaj71st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland3rd Department of Cardiology, Silesian Center for Heart Disease, Faculty of Medical University of Silesia, 41-800 Zabrze, Poland1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland1st Department of Cardiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland<b>Background/Objectives</b>: Heart failure (HF) constitutes a complex clinical syndrome that is highly prevalent worldwide, comprises a serious prognosis, and results in a reduced quality of life. Exercise capacity is one of the most significant parameters involved in the prognosis in HF patients. Our objective was to evaluate the relationship between the selected cardiopulmonary exercise testing (CPET) parameters and the concentration of novel biomarker sST2 in a group of patients with heart failure with reduced ejection fraction (HFrEF). <b>Methods</b>: A group of 135 patients with HFrEF was enrolled in this prospective cohort study. Patients were in the stable phase of the disease in the prior 4 weeks and received optimal medical treatment. Clinical and biochemical parameters were investigated. All patients performed maximal CPET. <b>Results</b>: The mean (SD) concentration of sST2 was 45.5 ± 39.2 ng/mL. Based on the CPET results, the cut-off value (52.377 ng/mL) was established, optimal for the discrimination of relative peakVO<sub>2</sub> < 12 mL/kg/min. Patients were divided into two groups according to sST2 cut-off values determined with an ROC curve (AUC 0.692, 95% CI: 0.567–0.816). The mean relative peakVO<sub>2</sub> in patients with higher sST2 was 14.5 ± 4.6 mL/kg/min, while in the second group, it was 17.6 ± 5.2 (<i>p</i> = 0.002). In the sST2 ≥ 52.377 ng/mL group, 55.6% of patients achieved VO<sub>2</sub> < 50%. Subjects with lower sST2 values obtained higher values of PETCO<sub>2</sub> (<i>p</i> < 0.001) and higher values of pulse O<sub>2</sub> (<i>p</i> = 0.01). VE/VCO<sub>2</sub>slope (<i>p</i> = 0.002) was higher in patients with increased sST2 concentration. <b>Conclusions</b>: The concentration of sST2 protein is substantially associated with the clinical severity of heart failure with reduced left ventricular ejection fraction assessed by functional capacity through CPET.https://www.mdpi.com/2227-9059/13/1/60ST2sST2biomarkercardiopulmonary exercise testingCPETheart failure
spellingShingle Magdalena Dudek
Marta Kałużna-Oleksy
Filip Sawczak
Agata Kukfisz
Aleksandra Soloch
Jacek Migaj
Maciej Lesiak
Ewa Straburzyńska-Migaj
The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
Biomedicines
ST2
sST2
biomarker
cardiopulmonary exercise testing
CPET
heart failure
title The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
title_full The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
title_fullStr The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
title_full_unstemmed The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
title_short The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
title_sort usefulness of soluble st2 concentration in heart failure with reduced ejection fraction to predict severe impairment in exercise capacity assessed in cardiopulmonary exercise testing
topic ST2
sST2
biomarker
cardiopulmonary exercise testing
CPET
heart failure
url https://www.mdpi.com/2227-9059/13/1/60
work_keys_str_mv AT magdalenadudek theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT martakałuznaoleksy theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT filipsawczak theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT agatakukfisz theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT aleksandrasoloch theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT jacekmigaj theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT maciejlesiak theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT ewastraburzynskamigaj theusefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT magdalenadudek usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT martakałuznaoleksy usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT filipsawczak usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT agatakukfisz usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT aleksandrasoloch usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT jacekmigaj usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT maciejlesiak usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting
AT ewastraburzynskamigaj usefulnessofsolublest2concentrationinheartfailurewithreducedejectionfractiontopredictsevereimpairmentinexercisecapacityassessedincardiopulmonaryexercisetesting